Published in Gut on November 01, 2004
Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol (2006) 1.79
Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun (2006) 1.38
Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol (2015) 1.34
Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut (2006) 1.26
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut (2006) 1.24
T cell apoptosis and inflammatory bowel disease. Gut (2004) 1.00
Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS One (2008) 0.97
Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro. Eur J Nutr (2008) 0.86
Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase. PLoS One (2011) 0.86
Increased levels of survivin, via association with heat shock protein 90, in mucosal T cells from patients with Crohn's disease. Gastroenterology (2012) 0.81
Osteopontin: a new addition to the constellation of cytokines which drive T helper cell type 1 responses in Crohn's disease. Gut (2005) 0.80
Crohn's disease with gastroduodenal involvement: Diagnostic approach. World J Clin Cases (2015) 0.79
Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases. Prz Gastroenterol (2014) 0.77
Immunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis. PLoS One (2013) 0.77
Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn's disease. J Gastroenterol (2013) 0.76
Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death. Cancer Res (2016) 0.75
On the genetic involvement of apoptosis-related genes in Crohn's disease as revealed by an extended association screen using 245 markers: no evidence for new predisposing factors. J Negat Results Biomed (2005) 0.75
p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04
CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 24.83
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
The biochemistry of apoptosis. Nature (2000) 18.91
Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev (1995) 13.66
G1 phase progression: cycling on cue. Cell (1994) 11.62
Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology (1998) 9.58
Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med (2001) 7.46
Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature (1997) 6.23
Cell death in development. Cell (1999) 6.01
Helper T cell differentiation is controlled by the cell cycle. Immunity (1998) 5.71
Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell (1999) 4.83
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol (1995) 4.81
Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res (1997) 4.22
Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene (1995) 3.96
The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem (1999) 3.32
Functional characterization and developmental regulation of mouse telomerase RNA. Science (1995) 3.26
The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol (2000) 3.12
Telomeres in T and B cells. Nat Rev Immunol (2002) 2.76
A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry (1985) 2.72
Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol (1997) 2.71
Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet (2001) 2.64
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58
IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol (1999) 2.58
Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol (1996) 2.42
Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol (1999) 2.38
Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc Natl Acad Sci U S A (1998) 2.26
Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut (2002) 2.26
Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol (1999) 2.11
Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry (1998) 2.11
Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today (1993) 2.09
Instruction for cytokine expression in T helper lymphocytes in relation to proliferation and cell cycle progression. J Exp Med (1999) 2.09
Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology (1992) 1.98
Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology (1992) 1.92
Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut (2001) 1.92
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut (1998) 1.88
Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology (1999) 1.78
The art of the probable: system control in the adaptive immune system. Science (2001) 1.77
Quantification of cell turnover kinetics using 5-bromo-2'-deoxyuridine. J Immunol (2000) 1.67
Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J Immunol (1995) 1.62
Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem (1995) 1.59
Premature ageing of the immune system: the cause of AIDS? Trends Immunol (2002) 1.55
Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur J Immunol (1993) 1.51
Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology (1984) 1.49
High frequencies of telomeric associations, chromosome aberrations, and sister chromatid exchanges in ulcerative colitis. Am J Gastroenterol (2000) 1.48
Enhancing Lamina propria Th1 cell responses with interleukin 12 produces severe tissue injury. Gastroenterology (1999) 1.41
Selective resistance of mucosal T-cell activation to immunosuppression in Crohn's disease. Dig Liver Dis (2001) 1.39
Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity. Gastroenterology (1996) 1.31
Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol (1998) 1.24
Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol (1997) 1.18
Macrophages resistant to endogenously generated nitric oxide-mediated apoptosis are hypersensitive to exogenously added nitric oxide donors: dichotomous apoptotic response independent of caspase 3 and reversal by the mitogen-activated protein kinase kinase (MEK) inhibitor PD 098059. Proc Natl Acad Sci U S A (1998) 1.07
T cell effector function and anergy avoidance are quantitatively linked to cell division. J Immunol (2000) 1.06
Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls. Gastroenterology (1989) 1.05
The molecular regulation of lymphocyte apoptosis. Semin Immunol (1997) 1.05
Responses to self and non-self intestinal microflora in health and inflammatory bowel disease. Res Immunol (1998) 0.98
Telomere length, aging, and somatic cell turnover. J Exp Med (1999) 0.97
Telomeres, telomerase, and cancer. N Engl J Med (2000) 0.97
Advances in intestinal T-cell development and function. Immunol Today (1995) 0.94
Estimation of kinetic cell-cycle-related gene expression in G1 and G2 phases from immunofluorescence flow cytometry data. Cytometry (1999) 0.94
Cell-cycle regulation in immunity, tolerance and autoimmunity. Immunol Today (2000) 0.93
p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling. J Clin Invest (2002) 0.93
Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease. Gastroenterology (1992) 0.86
Apoptosis: implications for inflammatory bowel disease. Inflamm Bowel Dis (2000) 0.86
Simultaneous estimation of T(G2+M), T(S), and T(pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry. Cytometry (2000) 0.85
Simultaneous detection of cyclin B1, p105, and DNA content provides complete cell cycle phase fraction analysis of cells that endoreduplicate. Cytometry (1999) 0.83
Intrinsic hyperreactivity of mucosal T cells to interleukin-2 in pediatric Crohn's disease. J Pediatr (1998) 0.83
T cell development: some cells get all the breaks. Nat Immunol (2000) 0.81
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis (2010) 6.75
Comparison of the complete protein sets of worm and yeast: orthology and divergence. Science (1998) 6.28
A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim (1999) 4.93
Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol (1995) 2.71
Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet (2001) 2.64
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease. Inflamm Bowel Dis (2010) 2.17
Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol (1999) 2.11
Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation (1983) 2.05
Comparison of transcutaneous and endtidal CO2-monitoring for rigid bronchoscopy during high-frequency jet ventilation. Acta Anaesthesiol Scand (2003) 2.02
Review article: breath analysis in inflammatory bowel diseases. Aliment Pharmacol Ther (2014) 2.02
Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut (2001) 1.92
Xenografts of primary human prostatic carcinoma. J Natl Cancer Inst (1993) 1.80
Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology (1993) 1.75
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis (2013) 1.67
Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization. Dig Dis Sci (1979) 1.60
Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases. Am J Gastroenterol (2004) 1.59
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut (2003) 1.56
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases. Aliment Pharmacol Ther (2009) 1.54
Hierarchical cleavage of focal adhesion kinase by caspases alters signal transduction during apoptosis of intestinal epithelial cells. Gastroenterology (2001) 1.52
Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology (1997) 1.51
Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients. Gastroenterology (1986) 1.50
Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology (1984) 1.49
Clinical experience with a new endoscopic over-the-scope clip system for use in the GI tract. Dig Liver Dis (2008) 1.45
Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation (1986) 1.41
Selective resistance of mucosal T-cell activation to immunosuppression in Crohn's disease. Dig Liver Dis (2001) 1.39
Intestinal immunity and inflammation: recent progress. Gastroenterology (1986) 1.32
Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity. Gastroenterology (1996) 1.31
Immortalization and characterization of proximal tubule cells derived from kidneys of spontaneously hypertensive and normotensive rats. Kidney Int (1996) 1.30
Immunoregulatory function of lamina propria T cells in Crohn's disease. Gastroenterology (1985) 1.27
Receptor subtypes mediating adenosine-induced dilation of cerebral arterioles. Am J Physiol Heart Circ Physiol (2001) 1.26
Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Dig Dis Sci (1988) 1.24
The human type 2 iodothyronine deiodinase is a selenoprotein highly expressed in a mesothelioma cell line. J Biol Chem (2001) 1.23
Flow cytometric titration of retroviral expression vectors: comparison of methods for analysis of immunofluorescence histograms derived from cells expressing low antigen levels. Cytometry (1993) 1.23
A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism. J Lipid Res (1986) 1.20
The CD40/CD40L costimulatory pathway in inflammatory bowel disease. Gut (2004) 1.18
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut (2007) 1.18
Fixation of mammalian cells for flow cytometric evaluation of DNA content and nuclear immunofluorescence. Cytometry (1992) 1.17
Religious beliefs in schizophrenia: their relevance for adherence to treatment. Schizophr Bull (2007) 1.15
High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. J Rheumatol (2000) 1.15
Developing the skill of endotracheal intubation: implication for emergency medicine. Acta Anaesthesiol Scand (2011) 1.14
Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma. Dig Dis Sci (1988) 1.13
McArdle's disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia. Acta Anaesthesiol Scand (2005) 1.12
Cerebral vasomotor changes in the transient syndrome of headache with neurologic deficits and CSF lymphocytosis (HaNDL). Headache (1997) 1.12
ATP-sensitive K+ channels in rat aorta and brain microvascular endothelial cells. Am J Physiol (1993) 1.11
HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res Hum Retroviruses (1995) 1.11
CD4 positive Leu-8 negative helper-inducer T cells predominate in the human intestinal lamina propria. J Immunol (1988) 1.11
Analysis of simian virus 40 infection of CV-1 cells by quantitative two-color fluorescence with flow cytometry. Cytometry (1988) 1.11
New isolation technique to study apoptosis in human intestinal epithelial cells. Am J Pathol (1998) 1.10
Proinflammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells. Gastroenterology (1998) 1.10
Analysis of intracellular antigens by flow cytometry. Cytometry (1986) 1.10
Sequential and rapid activation of select caspases during apoptosis of normal intestinal epithelial cells. Am J Physiol (1998) 1.10
Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study. Aliment Pharmacol Ther (2013) 1.09
Human intestinal mucosal mononuclear cells exhibit lymphokine-activated killer cell activity. Gastroenterology (1985) 1.08
Commentary: Adjunct antibiotic combination therapy for ulcerative colitis--is it time to investigate Fusobacterium varium? Aliment Pharmacol Ther (2014) 1.08
Commentary: antibodies reacting with the infliximab Fab portion--something new? Aliment Pharmacol Ther (2013) 1.07
Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome. Aliment Pharmacol Ther (2013) 1.07
Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. Gastroenterology (1991) 1.07
Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis. Gut (1993) 1.07
Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease. Lancet (1998) 1.06
The VS catalytic RNA replicates by reverse transcription as a satellite of a retroplasmid. Genes Dev (1995) 1.06
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol (2013) 1.06
Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls. Gastroenterology (1989) 1.05
Immortalization of immature and mature mouse astrocytes with SV40 T antigen. J Neurosci Res (1994) 1.05
Regulation of blood-brain barrier endothelial cells by nitric oxide. Circ Res (1994) 1.05
Benign nodular fasciitis originating in Tenon's capsule. Arch Ophthalmol (1966) 1.04
Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. J Neuroimmunol (1994) 1.03
Correlation of sinus slowing and hyperpolarization caused by adenosine in sinus node. Pflugers Arch (1985) 1.03
Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T cells and enhanced proliferation to Staphylococcus aureus and lipopolysaccharides. Dig Dis Sci (1981) 1.03
Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2005) 1.02
Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways. Rev Physiol Biochem Pharmacol (1996) 1.02
Stage D1 adenocarcinoma of prostate. Urology (1984) 1.02
Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease. Gut (2007) 1.01
Amino acid position 11 of HLA-DRβ1 is a major determinant of chromosome 6p association with ulcerative colitis. Genes Immun (2011) 1.01
Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. J Clin Invest (1998) 1.00
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease. Am J Gastroenterol (2001) 0.99
Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. Infect Immun (1999) 0.98
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2009) 0.98
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma. Clin Cancer Res (1999) 0.97
Effect of ethnic origin of mother on fetal outcome. Arch Dis Child Fetal Neonatal Ed (1994) 0.96
Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease. Aliment Pharmacol Ther (2000) 0.96
Pathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol (1999) 0.95
Transforming growth factor-beta1 preserves epithelial barrier function: identification of receptors, biochemical intermediates, and cytokine antagonists. J Cell Physiol (1999) 0.95
Regulation of NIH-3T3 cell G1 phase transit by serum during exponential growth. Cell Prolif (1995) 0.95
Effects of adenosine and adenine nucleotides on the atrioventricular node of isolated guinea pig hearts. Circulation (1984) 0.95
Early atherosclerosis in patients with inflammatory bowel disease. Eur Rev Med Pharmacol Sci (2006) 0.94
Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes. Blood (1999) 0.94
Melioidosis-laboratory studies. Health Lab Sci (1969) 0.94
The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer Res (2001) 0.94